• Chamindra G Konersman, Brett J Bordini, Gunter Scharer, Michael W Lawlor, Steven Zangwill, James F Southern, Louella Amos, Gabrielle C Geddes, Robert Kliegman, and Michael P Collins.
• Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, USA. Electronic address: ckonersman@ucsd.edu.
• Neuromuscul. Disord. 2015 May 1; 25 (5): 418-22.

AbstractMyofibrillar myopathies (MFMs) are a heterogeneous group of neuromuscular disorders distinguished by the pathological hallmark of myofibrillar dissolution. Most patients present in adulthood, but mutations in several genes including BCL2-associated athanogene 3 (BAG3) cause predominantly childhood-onset disease. BAG3-related MFM is particularly severe, featuring weakness, cardiomyopathy, neuropathy, and early lethality. While prior cases reported either neuromuscular weakness or concurrent weakness and cardiomyopathy at onset, we describe the first case in which cardiomyopathy and cardiac transplantation (age eight) preceded neuromuscular weakness by several years (age 12). The phenotype comprised distal weakness and severe sensorimotor neuropathy. Nerve biopsy was primarily axonal with secondary demyelinating/remyelinating changes without "giant axons." Muscle biopsy showed extensive neuropathic changes that made myopathic changes difficult to interpret. Similar to previous cases, a p.Pro209Leu mutation in exon 3 of BAG3 was found. This case underlines the importance of evaluating for MFMs in patients with combined neuromuscular weakness and cardiomyopathy. Copyright © 2015 Elsevier B.V. All rights reserved.

33 keywords...

hide…